Tuyen Ong is the founder of Ring Therapeutics. Ring Therapeutics has raised $117M in total funding. Latest round: Series B. Based in Cambridge, MA.
Tuyen Ong is the CEO of Ring Therapeutics, a life sciences company founded by Flagship Pioneering. Ring Therapeutics aims to revolutionize gene therapy using its commensal virome platform. The company recently raised $117 million in Series B funding, building on its previous funding rounds. Prior to his current role, Ong served as CEO-Partner of Flagship Pioneering.
Full founder directory · Investor directory · Company funding database · Fundraising library